Biotechnology Business, Law, and Science
3.6 (11 ratings)
Instead of using a simple lifetime average, Udemy calculates a course's star rating by considering a number of different factors such as the number of ratings, the age of ratings, and the likelihood of fraudulent ratings.
289 students enrolled
Wishlisted Wishlist

Please confirm that you want to add Biotechnology Business, Law, and Science to your Wishlist.

Add to Wishlist

Biotechnology Business, Law, and Science

Deep knowledge on the biotechnology industry: business, law, regulations, policy, and science
3.6 (11 ratings)
Instead of using a simple lifetime average, Udemy calculates a course's star rating by considering a number of different factors such as the number of ratings, the age of ratings, and the likelihood of fraudulent ratings.
289 students enrolled
Created by Dr. Yali Friedman
Last updated 1/2014
English
Learn Fest Sale
Current price: $10 Original price: $25 Discount: 60% off
2 days left at this price!
30-Day Money-Back Guarantee
Includes:
  • 6.5 hours on-demand video
  • Full lifetime access
  • Access on mobile and TV
  • Certificate of Completion
What Will I Learn?
  • Understand the commercial factors driving and constraining biotechnology development
  • Learn how biotechnology is regulated, and how regulations can both limit and drive innovation
  • Learn about patents and other forms of intellectual property protection in biotechnology, and why they are crucial for innovation
  • Learn about domestic and international biotechnology policy decisions and how to balance innovation incentives with economic realities
  • Learn about the science behind biotechnology, and it applications
View Curriculum
Requirements
  • This course presumes no former training in business, science, or law.
Description

Learn the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies.

Going beyond simple 'science for non-scientists' or 'mini MBA' offerings, this course describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.

This course is based on the leading business-of-biotechnology text, "Building Biotechnology," which has been adopted by more than 50 schools, and is taught by Yali Friedman, Ph.D., chief editor of the Journal of Commercial Biotechnology and a former instructor of biotechnology management at the National Institutes of Health.

Who is the target audience?
  • New hires to biotechnology and related companies
  • New biotechnology founders
  • Scientists and other entrepreneurs seeking to better understand the business of biotechnology
Students Who Viewed This Course Also Viewed
Curriculum For This Course
Expand All 57 Lectures Collapse All 57 Lectures 06:32:47
+
Welcome and overview
2 Lectures 03:21
+
Introduction
1 Lecture 05:49
+
The Development of Biotechnology
5 Lectures 19:13

Knowledge and Skills Enabling Biotechnology
04:24

Application
03:20

Biotechnology Industry Trends
03:02

Case Study: Company Examples
03:13
+
Science
1 Lecture 03:18
The Science of Biotechnology
03:18
+
Introduction to Molecular Biology
3 Lectures 19:42
Overview
04:15

The Roles of DNA, Genes, and Protein
13:42

The Big Picture
01:45
+
Drug Development
3 Lectures 21:46
Biotechnology vs. Pharmaceutical Methods
04:18

5 Basic Steps of Drug Development
15:34

Desirable Qualities of a Good Drug
01:54
+
Biotechnology Tools and Techniques
4 Lectures 20:11
Overview
01:23

Bioinformatics
05:51

Genomics and Proteomics
07:47

Biologic Drug Delivery and Nanotechnology
05:10
+
Biotechnology Applications
4 Lectures 45:12
Overview
03:31

Green Biotechnology: Agriculture
06:57

White Biotechnology: Industrial Processes and Bio-based Products
16:19

Red Biotechnology: Medical Applications
18:25
+
Laws, Regulations, and Policy
2 Lectures 05:06
Patents, Regulation, and Policy
01:35

Intellectual Property - Overview
03:31
+
Intellectual Property
5 Lectures 36:29
Patents
14:43

Patent Challenge and Exemptions
12:06

Trade Secrets
04:27

Trademark
03:12

The Role of Intellectual Property in Biotechnology
02:01
8 More Sections
About the Instructor
Dr. Yali Friedman
3.6 Average rating
11 Reviews
289 Students
1 Course
Publisher and Editor, Journal of Commercial Biotechnology

Yali Friedman, Ph.D. is chief editor of the Journal of Commercial Biotechnology, and publisher of DrugPatentWatch.com. His first book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development. He also serves on the science advisory board of Chakra Biotech, and is a judge for the Maryland Incubator Company of the Year Award.

Yali has strong exposure to leading issues in international biotechnology. He is lead editorial consultant for Scientific American's worldVIEW, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries since 2009, and has been invited to participate in biotechnology industry development forums for international groups such as APEC and for individual countries such as Japan, Canada, Germany, the Philippines, Turkey, and Taiwan.

Yali taught biotechnology management at the National Institutes of Health for many years and regularly guest-lectures for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.

Yali has a long history in biotechnology media. He created the first blog on the business of biotechnology for a NY Times company, which was named to Forbes "Best of the Web". His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, BiotechBlog.com, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence service based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.